Position in ALNY
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$1,977,940
-$2,410,923 QoQ
Shares Held
5,978
-45.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Banque Cantonale Vaudoise holds $13,170,474 across 21 Biotechnology names. ALNY ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,927 | $3,986,262 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
5,978 | $1,977,940 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,970 | $1,522,100 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
16,000 | $903,840 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
17,463 | $830,714 | |
| 6 | INSM |
INSMED Inc
|
3,923 | $641,488 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
23,916 | $453,447 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
862 | $451,231 |
All Filings in ALNY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,977,940 | 5,978 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,388,863 | 11,037 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,216,160 | 4,860 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,872,734 | 5,743 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,006,634 | 3,728 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $1,529,166 | 5,560 | Shares | Sole | 2024-11-08 | |
| 2023-09-30 | $364,471 | 2,058 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $930,706 | 4,900 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $560,896 | 2,800 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $665,420 | 2,800 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,261,008 | 6,300 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $408,380 | 2,800 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $457,212 | 2,800 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $474,824 | 2,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $585,311 | 3,100 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $525,512 | 3,100 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $437,689 | 3,100 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $181,958 | 1,400 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $553,280 | 3,800 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $414,559 | 2,799 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $272,125 | 2,500 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||